At low pO2 levels, mitochondria-targeted antioxidants improve myofilament Ca2+ sensitivity, increase PGC1α induction, and protect mitochondria, thereby improving symptoms of depression [35,36]. The gene discussed is PPARGC1A; the disease is major depressive disorder.